These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 23960017)

  • 1. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.
    Han Y; Chen Z; Yang Y; Jiang Z; Gu Y; Liu Y; Lin C; Pan Z; Yu Y; Jiang M; Zhou W; Cao X
    Hepatology; 2014 Feb; 59(2):567-79. PubMed ID: 23960017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD14(+) regulatory dendritic cells in patients with hepatocellular carcinoma and cirrhosis.
    Tanoue S; Kaplan DE
    Hepatology; 2016 Apr; 63(4):1391-2. PubMed ID: 26703333
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor-derived CD4+CD25+regulatory T cells inhibit dendritic cells function by CTLA-4.
    Chen X; Du Y; Hu Q; Huang Z
    Pathol Res Pract; 2017 Mar; 213(3):245-249. PubMed ID: 28214198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.
    Chen Y; Huang A; Gao M; Yan Y; Zhang W
    Int J Mol Med; 2013 Dec; 32(6):1366-72. PubMed ID: 24085111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-Cells induce regulatory T cells through TGF-β/IDO production in A CTLA-4 dependent manner.
    Nouël A; Pochard P; Simon Q; Ségalen I; Le Meur Y; Pers JO; Hillion S
    J Autoimmun; 2015 May; 59():53-60. PubMed ID: 25753821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
    Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
    Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma.
    Asghar K; Farooq A; Zulfiqar B; Rashid MU
    World J Gastroenterol; 2017 Apr; 23(13):2286-2293. PubMed ID: 28428708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
    Chen X; Du Y; Huang Z
    Immunol Lett; 2012; 148(1):83-9. PubMed ID: 23000301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow CD11b(+)F4/80(+) dendritic cells ameliorate collagen-induced arthritis through modulating the balance between Treg and Th17.
    Zhang L; Fu J; Sheng K; Li Y; Song S; Li P; Song S; Wang Q; Chen J; Yu J; Wei W
    Int Immunopharmacol; 2015 Mar; 25(1):96-105. PubMed ID: 25619457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.
    Boasso A; Herbeuval JP; Hardy AW; Winkler C; Shearer GM
    Blood; 2005 Feb; 105(4):1574-81. PubMed ID: 15466932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
    Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
    Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.
    Hu CE; Gan J; Zhang RD; Cheng YR; Huang GJ
    Scand J Gastroenterol; 2011 Feb; 46(2):156-64. PubMed ID: 20822377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.
    Korangy F; Ormandy LA; Bleck JS; Klempnauer J; Wilkens L; Manns MP; Greten TF
    Clin Cancer Res; 2004 Jul; 10(13):4332-41. PubMed ID: 15240519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive factor blockade in dendritic cells via siRNAs results in objective clinical responses.
    Sioud M; Mobergslien A; Sæbøe-Larssen S
    Methods Mol Biol; 2015; 1218():269-76. PubMed ID: 25319657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
    Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
    Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
    Kawano M; Itonaga I; Iwasaki T; Tsumura H
    Oncol Rep; 2013 Mar; 29(3):1001-6. PubMed ID: 23291864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.